Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Pazderka

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacology & Therapeutics|January 21, 2015
Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugsMichael Murray, Adam Hraiki, Mary Bebawy, et al.
Nanomaterials (Basel, Switzerland)|October 17, 2018
Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid DerivativesGabriela Garrastazu Pereira, Tristan Rawling, Michele Pozzoli, et al.
European Journal of Pharmacology|December 21, 2022
Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acidsMd Khalilur Rahman, Balasubrahmanyam Umashankar, Hassan Choucair, et al.
Journal of Pharmaceutical Sciences|July 31, 2025
Mitochondrial targeting and anticancer cell killing by arylurea-fatty acids containing in-chain sulfur atomsBala Umashankar, Curtis Pazderka, Edward York, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 1, 2019
Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cellsYassir Al-Zubaidi, Curtis Pazderka, Nooshin Koolaji, et al.
Chemical Science|June 7, 2021
Aryl urea substituted fatty acids: a new class of protonophoric mitochondrial uncoupler that utilises a synthetic anion transporterTristan Rawling, Hugo MacDermott-Opeskin, Ariane Roseblade, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|January 21, 2015
Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugsMichael Murray, Adam Hraiki, Mary Bebawy, et al.
Nanomaterials (Basel, Switzerland)|October 17, 2018
Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid DerivativesGabriela Garrastazu Pereira, Tristan Rawling, Michele Pozzoli, et al.
European Journal of Pharmacology|December 21, 2022
Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acidsMd Khalilur Rahman, Balasubrahmanyam Umashankar, Hassan Choucair, et al.
Journal of Pharmaceutical Sciences|July 31, 2025
Mitochondrial targeting and anticancer cell killing by arylurea-fatty acids containing in-chain sulfur atomsBala Umashankar, Curtis Pazderka, Edward York, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 1, 2019
Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cellsYassir Al-Zubaidi, Curtis Pazderka, Nooshin Koolaji, et al.
Chemical Science|June 7, 2021
Aryl urea substituted fatty acids: a new class of protonophoric mitochondrial uncoupler that utilises a synthetic anion transporterTristan Rawling, Hugo MacDermott-Opeskin, Ariane Roseblade, et al.
Pageof 1